about
Naloxone blocks ethanol-mediated appetitive conditioning and locomotor activation in adolescent rats.New pharmacological approaches for the treatment of alcoholism.Ethanol-induced social facilitation in adolescent rats: role of endogenous activity at mu opioid receptors.Rodent models and mechanisms of voluntary binge-like ethanol consumption: Examples, opportunities, and strategies for preclinical research.Gestational naltrexone ameliorates fetal ethanol exposures enhancing effect on the postnatal behavioral and neural response to ethanol.Effects of CRF1-receptor and opioid-receptor antagonists on dependence-induced increases in alcohol drinking by alcohol-preferring (P) rats.Assessing appetitive, aversive, and negative ethanol-mediated reinforcement through an immature rat model.Combining naltrexone and prazosin in a single oral medication decreases alcohol drinking more effectively than does either drug alone.Targeting endogenous mu- and delta-opioid receptor systems for the treatment of drug addiction.The delta(1) opioid receptor is a heterodimer that opposes the actions of the delta(2) receptor on alcohol intake.Milk consumption during adolescence decreases alcohol drinking in adulthood.Former Heroin-Dependent Alcohol Use Disorder Patients. Prevalence, Addiction History and Clinical Features.NF1 Is a Direct G Protein Effector Essential for Opioid Signaling to Ras in the Striatum.Pharmacotherapies for alcohol problems: a review of research with focus on developments since 1991.Dihydrocodeine/Agonists for alcohol dependentsCombining Varenicline (Chantix) with Naltrexone Decreases Alcohol Drinking More Effectively Than Does Either Drug Alone in a Rodent Model of Alcoholism.A Combination of Naltrexone + Varenicline Retards the Expression of a Genetic Predisposition Toward High Alcohol Drinking.
P2860
Q34288293-C6AE26A1-6C11-426F-B386-98B9EA5A357DQ34582243-3628FBDC-62F2-484A-8C3D-82CE1186FFDFQ34606762-6A7FF8A4-09FA-4CAE-8CC3-F373D6B9F366Q36342934-EA05D7DE-6AF1-41A9-92B4-C0FBBFB681A9Q36409468-4FC5A34C-46F6-4DC4-92C4-C0F5168F5B53Q36973049-F5ADD772-954E-4FE8-B260-E9E71C3ADD84Q37221255-F3D85292-8572-4AB6-B1A8-071D180D4592Q37227488-6FA1F77B-50CB-4AB1-AEC3-DE1593AE039AQ37363984-1C4DCAF1-E9A5-4FBF-8AA6-78636D549A7FQ37376376-593E1362-818D-4CFA-9C16-24E06DA27784Q37377937-E95BB462-9051-459B-BE12-774DBBFD48F5Q38397965-85EF509C-C4C6-406C-9EDC-0086170D1BAFQ38435406-9ACCD178-1A4D-459F-8E0C-43D4CF033035Q41159382-DD378089-596B-4B8A-A6EC-2BDA64770C1AQ42073257-4A06BBA8-5019-4999-B9D4-A036A53603F3Q42149212-56DCD7A4-EA66-436F-9240-FA6BFF19555CQ54998102-E33592EA-A80E-433C-BB5B-FB1D33E8D153
P2860
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
1994年论文
@zh
1994年论文
@zh-cn
name
Opioid involvement in alcohol drinking.
@en
type
label
Opioid involvement in alcohol drinking.
@en
prefLabel
Opioid involvement in alcohol drinking.
@en
P2860
P1476
Opioid involvement in alcohol drinking.
@en
P2093
P2860
P304
P356
10.1111/J.1749-6632.1994.TB19817.X
P407
P577
1994-10-01T00:00:00Z